Welcome to your Weekly Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
PBS Biotech Names Martin Simonetti as New CEO for Growth
PBS Biotech, a leading provider of innovative single-use bioreactor systems and bioprocess development services, has announced the appointment of Martin Simonetti as Chief Executive Officer, effective October 27, 2025. Simonetti brings over 40 years of experience in the biotechnology industry, including executive leadership, strategic financing, and managing large-scale pharmaceutical collaborations. As part of the company’s leadership transition, PBS founder Dr. Brian Lee will shift to the role of Chief Technology Officer, focusing on technology strategy and product innovation while remaining Chairman of the Board.
Kaigene Signs Exclusive Licensing Deal with Celltrion for Antibody Therapy
Kaigene Inc., a biotechnology company based in the United States and focused on developing next-generation antibody therapies for autoimmune disorders, has announced an exclusive global licensing agreement with Celltrion Inc., a leading international biopharmaceutical company. The agreement covers two of Kaigene’s nonclinical-stage assets, KG006 and KG002, allowing Celltrion to develop and commercialize these therapies worldwide, with the exception of Greater China and Japan for KG006.
LEO Pharma Appoints Sophie Lamle as Chief Development Officer
LEO Pharma, a leader in medical dermatology, announces the appointment of Sophie Lamle, D.Phil, as new Executive Vice President (EVP) of Development. Sophie will join the Global Leadership Team and will play an instrumental role in further strengthening LEO Pharma’sSearch & Development model.
Circle Pharma Appoints Rob Lauzen as Chief Financial Officer
Circle Pharma, Inc., a clinical-stage biopharmaceutical company developing next-generation macrocycle therapeutics to target cancer, announced the appointment of Rob Lauzen as its new Chief Financial Officer. Lauzen joins Circle Pharma with extensive experience in finance and capital strategy across the life sciences industry. He most recently served as CFO at Prilenia Therapeutics, where he led the company’s financial operations, capital planning, and investor relations initiatives.
Jopari Solutions Appoints John Gilmartin as President
Jopari Solutions, a leading healthcare technology company specializing in electronic billing, attachments, and payment solutions, has announced the appointment of John Gilmartin as President. Gilmartin, who has played a key role in the company’s recent expansion, will oversee daily operations and continue driving the organization’s strategic growth. Known for his thoughtful leadership and collaborative approach, he has helped strengthen relationships with customers and industry partners, earning respect across the organization and within the markets Jopari serves.
Aceso and Samsung Partner to Enhance Patient Engagement
Aceso Interactive, Inc., a leading provider of healthcare communication and patient engagement technology, has announced a strategic partnership with Samsung Electronics America to deliver advanced interactive care and digital signage solutions to hospitals and health systems across North America. This collaboration unites Samsung’s display innovation with Aceso’s enterprise software to meet the growing demand for connected, patient-centered experiences in modern healthcare settings.
To share your insights, please write to us at tony@intentamplify.com
